Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
09/30/2004 | WO2004083203A1 Compositions useful as protein kinase inhibitors |
09/30/2004 | WO2004083201A1 Pharmaceutical preparations containing arginine amides |
09/30/2004 | WO2004083200A1 Crystalline form of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
09/30/2004 | WO2004083199A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
09/30/2004 | WO2004083198A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators |
09/30/2004 | WO2004083187A1 Monocyclic anilide spirohydantoin cgrp receptor antagonists |
09/30/2004 | WO2004083174A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors |
09/30/2004 | WO2004083173A2 Ketopiperazine derivatives as bradykinin antagonists |
09/30/2004 | WO2004082687A1 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors |
09/30/2004 | WO2004082682A1 Amino cyclobutylamide modulators of chemokine receptor activity |
09/30/2004 | WO2004082678A1 Aryl spirohydantoin cgrp receptor antagonists |
09/30/2004 | WO2004082623A2 Substituted piperidine compounds |
09/30/2004 | WO2004082616A2 Tetrahydropyranyl cyclopentyl heterocylic amide modulators of chemokine receptor activity |
09/30/2004 | WO2004082602A2 Carboxamide spirohydantoin cgrp receptor antagonists |
09/30/2004 | WO2004058705B1 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
09/30/2004 | WO2004041209A3 Transcription factor modulating compounds and methods of use thereof |
09/30/2004 | WO2003014075A3 Novel gamma secretase inhibitors |
09/30/2004 | US20040192930 such as 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide for treatment of arthritis |
09/30/2004 | US20040192929 Process for the preparation of organic compounds containing a sulfinyl or sulfonyl group |
09/30/2004 | US20040192927 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof |
09/30/2004 | US20040192923 Method for the purification of lansoprazole |
09/30/2004 | US20040192922 Novel azole or triazole derivatives, method for preparing the same and use thereof as antifungal medicaments |
09/30/2004 | US20040192914 Compounds and methods |
09/30/2004 | US20040192757 Reacting a 2-pyrrolidinone with alpha-keto acid; cyclization, ammonolysis , catalytic hydrogenation |
09/30/2004 | US20040192752 Anti-HIV pyrazole derivatives |
09/30/2004 | US20040192750 Antiproliferative agents; anticancer agents; neurodegenerative agents sexual disorders; antidiabetic agents; urogenital disorders; antidiabetic agents; obesity; muscular disorders; aftertreatment surgery; autoimmune disease |
09/30/2004 | US20040192748 Heterocyclic compounds |
09/30/2004 | US20040192744 Inhibition of Histone Deacetylase; antiproliferative; antitumor: cell differentiation; 3,5-Dimethyl-isoxazole-4-carboxylic acid (2-amino-4,5-dichloro-phenyl)-amide |
09/30/2004 | US20040192743 Substituted azole derivatives as therapeutic agents |
09/30/2004 | US20040192736 New indoline compounds |
09/30/2004 | US20040192735 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
09/30/2004 | US20040192731 For agriculture crops |
09/30/2004 | US20040192729 Purification of antibodiees; elisa; neurotransmitter research; antidiabetic agents; skin disorders; antiinflammatory agents; antihistamines |
09/30/2004 | US20040192728 Antiinflammatory agents; analgesics |
09/30/2004 | US20040192727 Chromatography resolution; separation; purification |
09/30/2004 | US20040192726 Farnesyl protein transferase inhibitors for treating breast cancer |
09/30/2004 | US20040192725 Tyrosine kinase inhibitors |
09/30/2004 | US20040192722 Selective iGluR5 receptor antagonists |
09/30/2004 | US20040192720 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
09/30/2004 | US20040192712 Insecticides; for human or veterinary medicine |
09/30/2004 | US20040192710 Such as trans-4-amino-3,4-dihydro-2,2-dimethyl-6-cyano-2H-benzopyran; for use as antiarrhythmic agents |
09/30/2004 | US20040192703 Preferentially substituted calcium channel blockers |
09/30/2004 | US20040192701 Phenlypyridine carbonyl piperazine derivative |
09/30/2004 | US20040192700 Heating in solvent; controlling temperature; cooling; isolation; drying |
09/30/2004 | US20040192695 Reacting phthalidyl-3-triphenylphosphonium salt with 4-pyridine aldehyde in the presence of a basic adjuvant, then reacting with hydrazine hydrate and acid treatment; avoids environmental and safety problems |
09/30/2004 | US20040192693 Antidiabetic agents; arteriosclerosis; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents |
09/30/2004 | US20040192685 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
09/30/2004 | US20040192673 Obesity, non-insulin-dependent diabetes,strokes, sleep disorders; antiischemic and antiemetic agents |
09/30/2004 | US20040192670 For inhibiting bone resorption, treating/preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, aniogenesis, atherosclerosis, arthritis, tumor growth and metastasis |
09/30/2004 | US20040192668 3-(imidazolyl)-2-aminopropanoic acids |
09/30/2004 | US20040192667 Novel pyrazole analogs acting on cannabinoid receptors |
09/30/2004 | US20040192666 Nonnucleoside reverse transcriptase inhibitors |
09/30/2004 | US20040192653 P38 inhibitors and methods of use thereof |
09/30/2004 | US20040192612 For treating diseases of the central nervous system, preserving organ transplant tissues or blood; treating cancer via immunotherapy; various other autoimmune, cardiovascular, and viral diseases; 1-oxo-1H-isoquinoline pro-drug esters, amides, or hydroxamides that cross the blood brain barrier |
09/30/2004 | US20040191792 Acridone derivatives as labels for fluorescence detection of target materials |
09/30/2004 | US20040191210 Compounds |
09/30/2004 | CA2522176A1 Compositions useful as protein kinase inhibitors |
09/30/2004 | CA2519444A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
09/30/2004 | CA2519442A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
09/30/2004 | CA2519440A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
09/30/2004 | CA2519372A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators |
09/30/2004 | CA2519297A1 Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity |
09/30/2004 | CA2519220A1 Amino cyclobutylamide modulators of chemokine receptor activity |
09/30/2004 | CA2518852A1 Monocyclic anilide spirohydantoin cgrp receptor antagonists |
09/30/2004 | CA2518843A1 Aryl spirohydantoin cgrp receptor antagonists |
09/30/2004 | CA2518830A1 Carboxamide spirohydantoin cgrp receptor antagonists |
09/30/2004 | CA2517446A1 6-sulfonamide quinoline and chromene derivative as androgen receptor antagonists |
09/29/2004 | EP1462453A1 Paraphenylenediamin derivatives comprising a substituted pyrrolidinyl group and bearing a cationic radical as well as their use for dyeing keratinic fibres |
09/29/2004 | EP1462103A1 NO donors, combination products and uses as modulators of neurotransmitter release |
09/29/2004 | EP1461384A1 Novel flame retarding compounds |
09/29/2004 | EP1461334A2 Pyrazole derived kinase inhibitors |
09/29/2004 | EP1461321A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
09/29/2004 | EP1461318A2 Tetrahydroquinoline analogues as muscarinic agonists |
09/29/2004 | EP1461083A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
09/29/2004 | EP1461035A2 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents |
09/29/2004 | EP1461014A2 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
09/29/2004 | EP1192189B1 Catalysts containing n-pyrrolyl substituted nitrogen donors |
09/29/2004 | EP1181278B1 Cyclic amine derivatives and their uses |
09/29/2004 | EP1165557B1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS |
09/29/2004 | EP1114033B1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
09/29/2004 | EP1051397A4 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound |
09/29/2004 | EP1019040B1 Aryl ureas for the treatment of inflammatory or immunomodulatory diseases |
09/29/2004 | EP1003821B1 Anisotropic retardation layers for display devices |
09/29/2004 | EP0901487B9 2,3,6 trisubstituted-4(3h)-quinazolinones |
09/29/2004 | EP0805804B1 Sulphonyl amino(thio)carbonyl-1,2,4-triazolin(thi)one derivatives, the production thereof and the use thereof as herbicides |
09/29/2004 | CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use |
09/29/2004 | CN1533382A 哌嗪衍生物 Piperazine derivatives |
09/29/2004 | CN1533378A Process for production of quinazolines |
09/29/2004 | CN1533374A Substitutled cyclohexane-1,4-diamine derivatives |
09/29/2004 | CN1168727C Substituted benzimidazole |
09/29/2004 | CN1168721C 5-cyano-2-aminopyrimidine derivatives |
09/29/2004 | CN1168719C 6-phenylpyridyl-2-amine derivatives and pharmaceutical composition and use |
09/29/2004 | CN1168717C Novel intermediates for prepn. of antihisatminic piperidine derivatives |
09/29/2004 | CN1168715C Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them |
09/29/2004 | CN1168714C Arylpiperazine derivatives useful as uroselective alpha-adrenoceptor blockers |
09/29/2004 | CN1168709C Alpha-hydroxy, amino and fluoro derivatives of beta-sulphenyl hdyroxamic acids matrix metalloproteinase inhibitors |
09/29/2004 | CN1168704C Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide |
09/28/2004 | US6797825 Protein kinase inhibitors |
09/28/2004 | US6797824 Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands |
09/28/2004 | US6797823 Quinoline derivatives and quinazoline derivatives |